OCI Posts 6.6 Billion Won Operating Loss in Q3, Swings to Loss from Last Year

Deteriorating Performance Due to Weak Basic Chemical Market
Outlook for Securing New Customers in Q4
Synergy from P&O Chemical Merger Expected in Q4

OCI reported sales of 476.3 billion won and an operating loss of 6.6 billion won in the third quarter of this year. The company continued to post losses compared to the previous quarter and shifted from a profit to a loss compared to the same period last year.

On October 28, OCI announced its provisional results for the third quarter of 2025 through a public disclosure. The company explained that while there was an improvement in the spread of certain products and a reduction in losses at its Chinese subsidiary, OCI China, overall sales declined and one-off expenses were incurred, resulting in continued losses. In contrast to an operating profit of 17.7 billion won in the third quarter of last year, the company recorded an operating loss in the third quarter of this year.

The net loss for the period was 49.3 billion won, turning from a net profit of 13.9 billion won in the same period last year to a loss. OCI attributed this to a 70.5 billion won impairment loss related to the high softening point pitch production facilities of P&O Chemical, which was merged in September. The company stated that further improvement in results can be expected if new customers are secured or the facilities are utilized in the future.

OCI anticipates that the merger with P&O Chemical will lead to cost savings and enhanced operational efficiency.

This content was produced with the assistance of AI translation services.